GIA
ELI

Guyasuta Investment Advisors’s ELITE PHARMACEUTICAL ELI Stock Holding History

Guyasuta Investment Advisors’s Portfolio ELI Stock Details ELI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-60,000
Closed -$13K – 208
2015
Q3 		$13K Hold
60,000
– – ﹤0.01% 204
2015
Q2 		$12K Hold
60,000
– – ﹤0.01% 214
2015
Q1 		$15K Hold
60,000
– – ﹤0.01% 208
2014
Q4 		$13K Buy
60,000
+30,000
+100% +$6.5K ﹤0.01% 210
2014
Q3 		$9K Buy
+30,000
New +$9K ﹤0.01% 211

Other funds holding ELI

GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.26B AUM 31.39% 1-Year Est. Return
PCA
Personal Capital Advisors Redwood City, California $20.6B AUM 13.65% 1-Year Est. Return
WRM
Westport Resources Management Westport, Connecticut $138M AUM 14.6% 1-Year Est. Return

Guyasuta Investment Advisors's ELI Position: Q4 2015 in Review

Guyasuta Investment Advisors sold out of ELITE PHARMACEUTICAL (ELI) in Q4 2015, closing a stake of 60,000 shares — an estimated $13K sold.

Guyasuta Investment Advisors first reported a position in ELI in Q3 2014 and held it in 5 quarters. The position peaked at $15K in Q1 2015. 4 funds tracked by Wall St. Rank hold ELI as of Q4 2015.

  • Guyasuta Investment Advisors reported no remaining ELITE PHARMACEUTICAL position as of Q4 2015 after selling out during the quarter.
  • Guyasuta Investment Advisors sold 60,000 ELITE PHARMACEUTICAL shares in Q4 2015, an estimated $13K.
  • Guyasuta Investment Advisors first reported a position in ELITE PHARMACEUTICAL in Q3 2014 and held it in 5 quarters.
  • Guyasuta Investment Advisors's ELITE PHARMACEUTICAL position peaked at $15K in Q1 2015.
  • 4 funds tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q4 2015.

Based on Guyasuta Investment Advisors's 13F filing for Q4 2015, filed 5 Feb 2016.